The global ventilators market is entering a phase of steady technological evolution, with new data projecting the sector will grow from USD 3.86 billion in 2025 to USD 4.65 billion by 2029. According to the latest industry analysis, this represents a compound annual growth rate (CAGR) of 4.7%, fueled by an aging global population and the increasing prevalence of chronic respiratory conditions such as COPD and asthma.
The market landscape is shifting toward more versatile, “hybrid” solutions that support both invasive and non-invasive ventilation. While hospitals and clinics currently maintain the largest market share due to critical care infrastructure needs, the Home Care Settings segment is expected to witness the highest growth rate at 5.5% CAGR. This shift is largely attributed to the cost-efficiency of home-based therapies and the development of miniaturized, AI-integrated portable devices.
Key Market Highlights:
-
Dominant Segments: Intensive care ventilators accounted for 75.0% of the market share in 2024, reflecting the ongoing global investment in ICU infrastructure.
-
Regional Growth: The Asia Pacific region is slated to be the fastest-growing market (5.2% CAGR), driven by rapid urbanization, rising pollution levels, and increased healthcare spending in emerging economies like China and India.
-
Technological Disruptions: Integration of IoT for remote monitoring and AI-based decision support systems are becoming standard features for “Star” players such as ResMed, Getinge AB, and Philips.
Despite the positive outlook, the industry faces challenges, including a shortage of skilled medical practitioners and the high volume of ventilator inventory remaining from the COVID-19 pandemic. However, the move toward decentralized healthcare and the cost-effectiveness of remote patient monitoring continue to provide significant opportunities for manufacturers and healthcare providers alike.
Detailed insights into mobility, interface types, and regional forecasts are available in the full Ventilators Market Report.